AstraZeneca AB v. Glenmark Generics Ltd. et al > Summary
Court Case Number 1:14-cv-00665
Filing Date May 23, 2014
Court Delaware District Court
Status Unknown
Plaintiff
Defendant
Plaintiff Attorneys
4AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English
AstraZeneca
Attorney Name: Charles E. Lipsey
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English
Defendant Attorneys
5GLENMARK GENERICS LTD.
Attorney Name: Karen E. Keller
Shaw Keller LLP
GLENMARK GENERICS LTD.
Attorney Name: Adam W. Poff
Young Conaway Stargatt & Taylor
GLENMARK GENERICS LTD.
Attorney Name: John W. Shaw
Shaw Keller LLP
GLENMARK GENERICS LTD.
Attorney Name: Sarah M. Stensland
Carlson Caspers Vandenburgh & Lindquist, PA.
Counter Defendant
2Counter Claimant
4GLENMARK GENERICS LTD.
Attorney Name: Karen E. Keller
Shaw Keller LLP
GLENMARK GENERICS LTD.
Attorney Name: Adam W. Poff
Young Conaway Stargatt & Taylor
GLENMARK GENERICS LTD.
Attorney Name: John W. Shaw
Shaw Keller LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| RE044186 | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method | Apr 30, 2013 |
| 07951400 | Coated tablet formulation and method | May 31, 2011 |
